Transaction · 0000905148-26-004080

Schorno Dean L

Schorno Dean L, EVP, CFO, reported a transaction classified as exercise at RIGEL PHARMACEUTICALS INC involving 1286.000000 shares for an estimated $31121.20. Reported holdings after the transaction were 82962.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CFO
RIGLRIGEL PHARMACEUTICALS INC
Estimated value$31.1kShares × reported price
Shares traded1.28k$24.20 per share
Holdings after82.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RIGL price since this filing

Daily closing prices, with the filing date and available return windows
RIGL · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -18.9%1w ago +0.0%1d ago +0.0%
Returns since7d +2.5%30d +2.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000905148-26-004080
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 03, 2026, 11:02 PM · 1d delay
Shares
1,286 sh
$24.20 per share
Estimated value
$31.1k
Computed from shares × price
Holdings after
82,962 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 500 shares acquired under the Issuer's stock purchase plan.

  2. F2

    These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.

  3. F3

    The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the I…

  4. F4

    The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Iss…

  5. F5

    The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the Reporting Person's continuous service to the I…

  6. F6

    The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2020, subject to the Reporting Person's continuous service to the I…

Original filing · 0000905148-26-004080
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RIGL